Volume-weighted mean nuclear volume in renal cell carcinoma.

OBJECTIVES Tumor grade and stage are the most important prognostic parameters for renal cell carcinoma (RCC). The value of histologic nuclear grading, however, is impaired by the inconsistency of pathologists' observations. Estimate of volume-weighted mean nuclear volume (MNV), based on a stereologic method, is correlated with prognosis of bladder, prostate, and endometrial cancer. In this study, we investigated the prognostic value of stereologic estimation of nuclear volume in RCC. METHODS This study included 62 patients with RCC who underwent radical nephrectomy between 1989 and 1996. Patients were evaluated in two groups: patients with locally advanced and/or metastatic disease were part of the poor prognosis group and patients with localized disease were part of the good prognosis group. Unbiased estimates of MNV were compared with histologic grade, tumor stage, and growth pattern according to Thoenes classification. Group means were compared using the nonparametric Kruskal-Wallis one-way analysis of variance. Univariate analysis of the data was performed for MNV and time to death, metastasis, local recurrence, and disease-free survival by paired sample t test. For categorical variables, Pearson's correlation test was used for statistical analysis. RESULTS There was no correlation between MNV and patient sex, age, tumor stage, and growth pattern. MNV showed a trend to be higher in sarcomatoid and chromophilic cell types than in chromophobe and clear cell types (P < 0.05). MNV values were significantly higher with increasing grades but no MNV cutoff levels could be defined. The MNV values were not different between localized and locally advanced and/or metastatic disease. CONCLUSIONS Our results indicate that estimates of MNV are not useful for predicting disease outcome. Further studies are needed to set up reproducible intervals of tumor dedifferentiation that could be carried out in routine practice for predicting progression.

[1]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[2]  L. Medeiros,et al.  Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases , 1988, Cancer.

[3]  P. Lipponen,et al.  The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma , 1993, International journal of cancer.

[4]  O. Yoshida,et al.  Prognostic criteria in patients with prostate cancer: correlation with volume weighted mean nuclear volume. , 1995, The Journal of urology.

[5]  H. Sugao,et al.  Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features , 1993, Cancer.

[6]  H. Aburatani,et al.  Papillary Renal Cell Carcinoma: Quantitation of Chromosomes 7 and 17 by FISH, Analysis of Chromosome 3p for LOH, and DNA Ploidy , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[7]  W. Thoenes,et al.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. , 1986, Pathology, research and practice.

[8]  J. O'connor,et al.  Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma. , 1996, The Journal of urology.

[9]  R. Fietkau,et al.  Prognostic value of ploidy and proliferation markers in renal cell carcinoma , 1996, Cancer.

[10]  T. Ørntoft,et al.  Stereologic estimates of nuclear volume in noninvasive bladder tumors (Ta) correlated with the recurrence pattern , 1989, Cancer.

[11]  F. Marshall,et al.  Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. , 1993, Urology.

[12]  J. Baak,et al.  Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma , 1986, Cancer.

[13]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  G Raviv,et al.  The role of nuclear morphometry for predicting disease outcome in patients with localized renal cell carcinoma , 1995, Cancer.

[15]  J. Thrasher,et al.  Prognostic factors in renal cancer. , 1993, The Urologic clinics of North America.

[16]  L. Jeffrey Medeiros,et al.  Adult renal epithelial neoplasms. , 1995, American journal of clinical pathology.

[17]  Robert B. Shibuya,et al.  Stage I Renal Cell Carcinoma: A Clinicopathologic Study of 82 Cases , 1993, The American journal of surgical pathology.

[18]  A. Gelb Renal cell carcinoma , 1997 .

[19]  R. Stanley,et al.  Papillary renal cell carcinoma. A clinical, radiologic, and pathologic study of 34 cases , 1976, Cancer.

[20]  K Fujikawa,et al.  Role of volume weighted mean nuclear volume for predicting disease outcome in patients with renal cell carcinoma. , 1997, The Journal of urology.

[21]  K. O'toole,et al.  Pathology of benign and malignant kidney tumors. , 1993, The Urologic clinics of North America.

[22]  J. Ro,et al.  Sarcomatoid renal cell carcinoma: Clinicopathologic. A study of 42 cases , 1987, Cancer.

[23]  F. B. Sørensen,et al.  DNA level and stereologic estimates of nuclear volume in squamous cell carcinomas of the uterine cervix. A comparative study with analysis of prognostic impact , 1992, Cancer.

[24]  Y. Collan General principles of grading lesions in diagnostic histopathology. , 1989, Pathology, research and practice.

[25]  J. Portillo,et al.  Nuclear morphometry in prognosis of renal adenocarcinoma. , 1992, Urology.

[26]  F. B. Sørensen Objective histopathologic grading of cutaneous malignant melanomas by stereologic estimation of nuclear volume. Prediction of survival and disease-free period. , 1990, Cancer.

[27]  R. Moll,et al.  Chromophobe cell renal carcinoma and its variants—a report on 32 cases , 1988, The Journal of pathology.

[28]  J. Ruiz,et al.  Value of morphometry as an independent prognostic factor in renal cell carcinoma. , 1995, European urology.